Pharmaceutical Companies Performance Tables 2006

SUMMARY

Who are the winners and losers in the global pharmaceutical industry?

This essential fully updated business reference report, published by Espicom in September 2005, compares and contrasts the performance and fortunes of leading pharmaceutical companies. Each company is ranked against a range of key business and financial performance indicators, using reported figures from 2001 to 2005.

Importantly, the fully updated 2006 edition of the report includes the individual results for 104 companies. Up to five years of key data from the balance sheet, income statement and cash flow are presented.

Furthermore, you can compare the performance of companies within three geographical regions: North America, Japan and Europe.

Pharmaceutical Companies Performance Tables 2006 provides a unique opportunity to assess companies' past performance and potential future activity. Use it for competitor analysis, partnering, PR and performance benchmarking.

Key Facts

• 2005 year-end figures
• Contains detailed performance rankings for more than 100 leading pharmaceutical companies
• Includes individual company results
• Provides up to five years of data
• 338 pages
• Available in Adobe Acrobat pdf, via email or in print.

Extensive Contents

• Key Financial Indicators
• Pharmaceutical Sales
• Total Revenues
• Cost of Sales
• Operating Income
• Net Income
• Earnings per Share
• R&D Expenditure
• Capital Expenditure
• Return on Capital Employed
• Total Assets
• Foreign Sales
• Employees

TABLE OF CONTENTS

• Introduction and Methodology
• Company Notes
• US Dollar Exchange Rates
• Company Data
• Performance Tables
• Pharmaceutical Sales
  • Pharmaceutical Sales 2001-2005 (Local Currency, Million)
  • Companies Ranked by Pharmaceutical Sales 2005 (US$, Million)
  • Companies Ranked by Yearly Change in Pharmaceutical Sales (Local Currency, Million)
  • Companies Ranked by Five Year Change in Pharmaceutical Sales (Local Currency, Million)
  • Five Year Movement of Pharmaceutical Sales (US$, Million at 2001 Exchange Rates)
  • Five Year Change in Pharmaceutical Sales (Index Numbers)
• Revenues
  • Revenues 2001-2005 (Local Currency, Million)
  • Companies Ranked by Revenues 2005 (US$, Million)
  • Companies Ranked by Yearly Change in Revenues (Local Currency, Million)
  • Companies Ranked by Five Year Change in Revenues (Local Currency, Million)
  • Five Year Movement of Revenues (US$, Million at 2001 Exchange Rates)
  • Five Year Change in Revenues (Index Numbers)
• Operating Profit
  • Operating Profit 2001-2005 (Local Currency, Million)
  • Companies Ranked by Operating Profit 2005 (US$, Million)
  • Companies Ranked by Yearly Change in Operating Profit (Local Currency, Million)
  • Companies Ranked by Five Year Change in Operating Profit (Local Currency, Million)
  • Five Year Movement of Operating Profit (US$, Million at 2001 Exchange Rates)
  • Five Year Change in Operating Profit (Index Numbers)
• Net Profit
  • Net Profit 2001-2005 (Local Currency, Million)
  • Companies Ranked by Net Profit 2005 (US$, Million)
  • Companies Ranked by Yearly Change in Net Profit (Local Currency, Million)
  • Companies Ranked by Five Year Change in Net Profit (Local Currency, Million)
  • Five Year Movement of Net Profit (US$, Million at 2001 Exchange Rates)
  • Five Year Change in Net Profit (Index Numbers)
• R&D Expenditure
  • R&D Expenditure 2001-2005 (Local Currency, Million)
  • Companies Ranked by R&D Expenditure 2005 (US$, Million)
  • Companies Ranked by Yearly Change in R&D Expenditure (Local Currency, Million)
  • Companies Ranked by Five Year Change in R&D Expenditure (Local Currency, Million)
  • Five Year Movement of R&D Expenditure (US$, Million at 2001 Exchange Rates)
  • Five Year Change in R&D Expenditure (Index Numbers)
• Capital Expenditure
  • Capital Expenditure 2001-2005 (Local Currency, Million)
  • Companies Ranked by Capital Expenditure 2005 (US$, Million)
  • Companies Ranked by Yearly Change in Capital Expenditure (Local Currency, Million)
  • Companies Ranked by Five Year Change in Capital Expenditure (Local Currency, Million)
  • Five Year Movement of Capital Expenditure (US$, Million at 2001 Exchange Rates)
  • Five Year Change in Capital Expenditure (Index Numbers)
• Assets
  • Assets 2001-2005 (Local Currency, Million)
  • Companies Ranked by Assets 2005 (US$, Million)
  • Companies Ranked by Yearly Change in Assets (Local Currency, Million)
  • Companies Ranked by Five Year Change in Assets (Local Currency, Million)
  • Five Year Movement of Assets (US$, Million at 2001 Exchange Rates)
  • Five Year Change in Assets (Index Numbers)
• Em ployees
  • Employees 2001-2005
  • Companies Ranked by Employees 2005
  • Companies Ranked by Yearly Change in Employees
  • Companies Ranked by Five Year Change in Employees
  • Five Year Change in Employees (Index Numbers)
• Foreign Sales
  • Foreign Sales 2001-2005 (Local Currency, Million)
  • Companies Ranked by Foreign Sales 2005 (US$, Million)
  • Companies Ranked by Yearly Change in Foreign Sales (Local Currency, Million)
  • Companies Ranked by Five Year Change in Foreign Sales (Local Currency, Million)
  • Five Year Movement of Foreign Sales (US$, Million at 2001 Exchange Rates)
  • Five Year Change in Foreign Sales (Index Numbers)
• International Sales
  • International Sales 2001-2005 (Local Currency, Million)
  • Companies Ranked by International Sales 2005 (US$, Million)
  • Companies Ranked by Yearly Change in International Sales (Local Currency, Million)
  • Companies Ranked by Five Year Change in International Sales (Local Currency, Million)
  • Five Year Movement of International Sales (US$, Million at 2001 Exchange Rates)
  • Five Year Change in International Sales (Index Numbers)
• Cost of Sales
  • Cost of Sales 2001-2005 (Local Currency, Million)
  • Companies Ranked by Cost of Sales 2005 (US$, Million)
  • Companies Ranked by Yearly Change in Cost of Sales (Local Currency, Million)
  • Companies Ranked by Five Year Change in Cost of Sales (Local Currency, Million)
  • Five Year Movement of Cost of Sales (US$, Million at 2001 Exchange Rates)
  • Five Year Change in Cost of Sales (Index Numbers)
• Earnings per Share
  • Earnings per Share 2001-2005 (Local Currency)
  • Companies Ranked by Earnings per Share 2005 (US$)
  • Companies Ranked by Yearly Change in Earnings per Share (Local Currency)
  • Companies Ranked by Five Year Change in Earnings per Share (Local Currency)
  • Five Year Movement of Earnings per Share (US$ at 2001 Exchange Rates)
  • Five Year Change in Earnings per Share (Index Numbers)
• Return on Capital Em ployed
  • Return on Capital Employed 2001-2005 (Operating Profit as a % of Net Assets)
  • Companies Ranked by Return on Capital Employed 2005 (%)
  • Companies Ranked by Yearly Change in Return on Capital Employed (%)
  • Companies Ranked by Five Year Change in Return on Capital Employed (%)
• Profitability
  • Profitability 2001-2005 (Operating Profit as a % of Revenue)
  • Companies Ranked by Profitability 2005 (%)
  • Companies Ranked by Yearly Change in Profitability (%)
  • Companies Ranked by Five Year Change in Profitability (%)
• Productivity
  • Productivity 2001-2005 (US$, Revenue per Employee)
  • Companies Ranked by Productivity 2005 (US$)
  • Companies Ranked by Yearly Change in Productivity (US$)
  • Companies Ranked by Five Year Change in Productivity (US$)
  • Five Year Movement of Productivity (US$ at 2001 Exchange Rates)
  • Five Year Change in Productivity (Index Numbers)
• Research Rates
  • Research Rates 2001-2005 (R&D Expenditure as a % of Revenues)
  • Companies Ranked by Research Rates 2005 (%)
  • Companies Ranked by Yearly Change in Research Rates (%)
  • Companies Ranked by Five Year Change in Research Rates (%)
• Investment Rates
  • Investment Rates 2001-2005 (Capital Expenditure as a % of Assets)
  • Companies Ranked by Investment Rates 2005 (%)
  • Companies Ranked by Yearly Change in Investment Rates (%)
  • Companies Ranked by Five Year Change in Investment Rates (%)
• Regional Rankings
  • US Companies Ranked by Pharmaceutical Sales 2005 (US$, Million)
  • Japanese Companies Ranked by Pharmaceutical Sales 2005 (US$, Million)
  • European Companies Ranked by Pharmaceutical Sales 2005 (US$, Million)
  • US Companies Ranked by Revenues 2005 (US$, Million)
  • Japanese Companies Ranked by Revenues 2005 (US$, Million)
  • European Companies Ranked by Revenues 2005 (US$, Million)
• Company Results
  • 3M (US$, Million)
  • Abbott (US$, Million)
  • Abraxis BioScience (US$, Million)
  • Actavis (Euro, Million)
  • Ajinomoto (\, Million)
  • Akzo Nobel (Euro, Million)
  • Alcon (US$, Million)
  • Allergan (US$, Million)
  • Altana (Euro, Million)
  • Amgen (US$, Million)
  • Andrx (US$, Million)
  • Asahi Kasei (\, Million)
  • Aspen Pharmacare (R, Million)
  • AstraZeneca (US$, Million)
  • Barr Laboratories (US$, Million)
  • Baxter International (US$, Million)
  • Bayer (Euro, Million)
  • Biogen Idec (US$, Million)
  • Biovail (US$, Million)
  • Boehringer Ingelheim (Euro, Million)
  • Bristol-Myers Squibb (US$, Million)
  • Cambridge Antibody (UK£, Million)
  • Celgene (US$, Million)
  • Cephalon (US$, Million)
  • Chiesi (Euro, Million)
  • Chiron (US$, Million)
  • Cipla (IRs, Million)
  • CSL (A$, Million)
  • Daiichi (\, Million)
  • Dainippon Pharmaceutical (\, Million)
  • Dr Reddy's (IRs, Million)
  • Egis (HUF, Million)
  • Eisai (\, Million)
  • Elan (US$, Million)
  • Eli Lilly (US$, Million)
  • Endo Pharmaceuticals (US$, Million)
  • Forest Laboratories (US$, Million)
  • Fujisawa (\, Million)
  • Gedeon Richter (HUF, Million)
  • Genzyme (US$, Million)
  • Gilead Sciences (US$, Million)
  • GlaxoSmithKline (UK£, Million)
  • Hospira (US$, Million)
  • ImClone Systems (US$, Million)
  • Ipsen (Euro, Million)
  • Japan Tobacco (\, Million)
  • Johnson & Johnson (US$, Million)
  • King Pharmaceuticals (US$, Million)
  • Kirin (\, Million)
  • Kissei Pharmaceutical (\, Million)
  • Kos Pharmaceuticals (US$, Million)
  • KRKA (T, Million)
  • Kyorin (\, Million)
  • Kyowa Hakko Kogyo (\, Million)
  • Leo Pharmaceutical Products (DKr, Million)
  • Lundbeck (DKr, Million)
  • Mayne Group (A$, Million)
  • Medicis Pharmaceutical (US$, Million)
  • Medimmune (US$, Million)
  • Meiji Seika Kaisha (\, Million)
  • Merck & Co (US$, Million)
  • Merck KGaA (Euro, Million)
  • Millennium Pharmaceuticals (US$, Million)
  • Mitsubishi Chemical (\, Million)
  • Mylan Laboratories (US$, Million)
  • Nippon Kayaku (\, Million)
  • Nippon Shinyaku (\, Million)
  • Novartis (US$, Million)
  • Novo Nordisk (DKr, Million)
  • Ono Pharmaceutical (\, Million)
  • Orion (Euro, Million)
  • Otsuka (\, Million)
  • Pfizer (US$, Million)
  • Pliva (US$, Million)
  • Proctor & Gamble (US$, Million)
  • Ranbaxy (IRs, Million)
  • Recordati (Euro, Million)
  • Roche (SwFr, Million)
  • Sankyo (\, Million)
  • sanofi-aventis (Euro, Million)
  • Santen Pharmaceutical (\, Million)
  • Schering AG (Euro, Million)
  • Schering-Plough (US$, Million)
  • Schwarz Pharma (Euro, Million)
  • Sepracor (US$, Million)
  • Serono (US$, Million)
  • Shionogi (\, Million)
  • Shire Pharmaceuticals (UK£, Million)
  • Sigma-Tau (Euro, Million)
  • Solvay (Euro, Million)
  • Stada Arzneimittel (Euro, Million)
  • Sumitomo Chemical (\, Million)
  • Taisho Pharmaceutical (\, Million)
  • Takeda Chemical Industries (\, Million)
  • Tanabe Seiyaku (\, Million)
  • Teijin (\, Million)
  • Teva (US$, Million)
  • Tsumara (\, Million)
  • UCB (Euro, Million)
  • Valeant Pharmaceuticals (US$, Million)
  • Warner Chilcott (US$, Million)
  • Watson Pharmaceuticals (US$, Million)
  • Wyeth (US$, Million)
  • Yamanouchi Pharmaceutical (\, Million)